Citadel Advisors’s CARE.COM, INC. CRCM Stock Holding History

Citadel Advisors’s Portfolio CRCM Stock Details CRCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-25,300	Closed	-$380K	–	10572
2019 Q4	$380K	Buy	25,300 +9,700	+62%	+$116K	﹤0.01%	7235
2019 Q3	$163K	Buy	+15,600	New	+$161K	﹤0.01%	8263
2018 Q3	–	Sell	-22,100	Closed	-$461K	–	9960
2018 Q2	$461K	Buy	+22,100	New	+$413K	﹤0.01%	6506
2017 Q2	–	Sell	-10,800	Closed	-$135K	–	8350
2017 Q1	$135K	Buy	+10,800	New	+$107K	﹤0.01%	6740

Other funds holding CRCM

KTC

Kistler-Tiffany Companies Berwyn, Pennsylvania $616M AUM 16.74% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Citadel Advisors's CRCM Position: Q1 2020 in Review

Citadel Advisors sold out of CARE.COM, INC. (CRCM) in Q1 2020, closing a stake of 114,150 shares — an estimated $1.72M sold.

Citadel Advisors first reported a position in CRCM in Q1 2014 and held it in 17 quarters. The position peaked at $4.79M in Q2 2019. 2 funds tracked by Wall St. Rank hold CRCM as of Q1 2020.

Citadel Advisors reported no remaining CARE.COM, INC. position as of Q1 2020 after selling out during the quarter.
Citadel Advisors sold 114,150 CARE.COM, INC. shares in Q1 2020, an estimated $1.72M.
Citadel Advisors first reported a position in CARE.COM, INC. in Q1 2014 and held it in 17 quarters.
Citadel Advisors's CARE.COM, INC. position peaked at $4.79M in Q2 2019.
2 funds tracked by Wall St. Rank held CARE.COM, INC. as of Q1 2020.

Based on Citadel Advisors's 13F filing for Q1 2020, filed 15 May 2020.